Apertura and FAST Partner on Angelman Gene Therapy Innovation
Austin, Texas & New York, August 5, 2026 The Foundation for Angelman Syndrome Therapeutics (FAST) has announced a strategic...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Austin, Texas & New York, August 5, 2026 The Foundation for Angelman Syndrome Therapeutics (FAST) has announced a strategic...
New York, August 4, 2026 AEYE Health has announced the publication of a real-world clinical study in the British...
Aurora, Colorado, August 3, 2026 A University of Colorado Anschutz Medical Campus-led multicenter clinical trial has demonstrated that an...
SILVER SPRING, Md., July 29, 2026 The U.S. Food and Drug Administration (FDA) has licensed Ezplaz Freeze Dried Plasma...
NANJING, China, August 3, 2026 Leads Biolabs announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
VANCOUVER, BC, July 29, 2026 Victory Square Technologies Inc. has provided an update on Hydreight Technologies and its broader...
ORLANDO, Fla., July 30, 2026 Andor Health announced that its AI-native clinical services operating platform, ThinkAndor®, has reached General...
MENLO PARK, Calif., July 31, 2026 Hippocratic AI has launched a new suite of Rapid Response Climate Agents, enabling...
NEW YORK, July 30, 2026 DarioHealth Corp. has unveiled its Integrated GLP-1 Program, a comprehensive healthcare solution that combines...
